KIDRON MIRIAM (Chief Scientific Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 2/11/2025ACC: 0001213900-25-012241
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
+192.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
192.67K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+74K
Price / share
—
Trade value
—
% of position
7.4%
2/11/2025
1M→1.07M
Common Stock
Direct
Shares
+52K
Price / share
—
Trade value
—
% of position
4.8%
2/11/2025
1.07M→1.13M
Common Stock
Direct
Shares
+66.67K
Price / share
—
Trade value
—
% of position
5.9%
2/11/2025
1.13M→1.19M
Total
Net shares
+192.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2025 | A · Award | +74K | — | — | 7.4% | 1M | 1.07M |
| Common Stock Direct | 2/11/2025 | A · Award | +52K | — | — | 4.8% | 1.07M | 1.13M |
| Common Stock Direct | 2/11/2025 | A · Award | +66.67K | — | — | 5.9% | 1.13M | 1.19M |
| Total | +192.67K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported